Author profile

B. Lynn Beattie, MD, FRCPC

hide first letter

Letters / January/February 2005

In the September issue of this journal, several articles reviewed and endorsed the use of cholinesterase inhibitors in the treatment of Alzheimer disease. These included a report of a consensus conference (TREAD)[1]... Read More